Pharma Mar SA 2019 SR
The report highlights PharmaMar Group's 2019 performance in the biopharmaceutical sector, focusing on the discovery and commercialization of marine-derived oncology treatments. Key achievements include the filing of a new drug application for Lurbinectedin in the US and the divestment of the consumer chemicals business to focus on core biopharmaceuticals. The company maintained a strong commitment to R&D, investing 42% of its revenues into research. Environmental efforts were underscored by ISO 14001 certification and a focus on minimizing the impact of marine sample collection. Socially, the group reported a workforce with 58% women and emphasized occupational health and safety through OHSAS 18001 certification.
Company: Pharma Mar SA
Sector: Manufacturing
Country: Spain
Year: 2019
Type: SR
Pages: 64
Pharma Mar SA
The report highlights PharmaMar Group's 2019 performance in the biopharmaceutical sector, focusing on the discovery and commercialization of marine-derived oncology treatments. Key achievements include the filing of a new drug application for Lurbinectedin in the US and the divestment of the consumer chemicals business to focus on core biopharmaceuticals. The company maintained a strong commitment to R&D, investing 42% of its revenues into research. Environmental efforts were underscored by ISO 14001 certification and a focus on minimizing the impact of marine sample collection. Socially, the group reported a workforce with 58% women and emphasized occupational health and safety through OHSAS 18001 certification.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2019
Reporting Period
Jan 1, 2019 - Dec 31, 2019
Fiscal Year
2019
Published
Feb 26, 2020
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
Sustainable Development Goals
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Water Consumption
Women on Board
Women in Management
Employees